Picture of Poxel SA logo

POXEL — Poxel SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Poxel Q1 Revenue Down At EUR 14.9 Million

April 8 (Reuters) - Poxel SA  POXEL.PA :
    * POXEL ANNOUNCES FIRST QUARTER 2019 FINANCIAL UPDATE
    * Q1 REVENUE EUR 14.9 MILLION VERSUS EUR 18.3 MILLION YEAR AGO
    * THIS YEAR WILL BE VERY IMPORTANT FOR POXEL-CEO
    * Q1 CASH AND CASH EQUIVALENTS EUR 59.0 MILLION VERSUS EUR 66.7 MILLION IN
Q4 2018
    * THERE WILL BE SEVERAL SIGNIFICANT MILESTONES THAT HAVE POTENTIAL FOR
SUBSTANTIAL
VALUE CREATION-CEO
    * WE PLAN TO INITIATE A PIVOTAL PHASE 2 PROGRAM IN BIOPSY-PROVEN NASH
PATIENTS IN
THE FOURTH QUARTER OR EARLY 2020
    * FOR PXL065, DURING Q2 2019, PLANS TO INITIATE THE PHASE 1B MULTIPLE
ASCENDING
DOSE STUDY, RESULTS EXPECTED DURING Q3 2019

Source text for Eikon:  ID:nBw5gf3Lka 
Further company coverage:  POXEL.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Poxel SA

See all news